期刊文献+

快速性心律失常患儿血清N末端脑型钠尿肽的变化 被引量:1

Changes of N terminal pro brain natriuretic peptide in serum of children with tachyarrhythmia
下载PDF
导出
摘要 目的:探讨快速性心律失常患儿转律前后血清N末端脑型钠尿肽(NT-proBNP)的变化,并评价其对心律失常的临床诊断、预后评估作用。方法:收治快速性心律失常患儿60例,快速性心律失常转律前后测定血清NT-proBNP水平及左心室射血分数(EF)、左室舒张末期直径(LVDD),健康儿童60例作为对照组,测定血清NT-proBNP水平及EF、LVDD。结果:快速性心律失常转律前的NT-proBNP水平明显高于快速性心律失常转律后1周的NT-proBNP水平和对照组NT-proBNP水平,差异均有统计学意义。快速性心律失常转律后1周的NT-proBNP水平与健康对照组比较无统计学意义;快速性心律失常转律前的EF、LVDD与快速性心律失常转律后1周以及健康对照组比较无统计学意义。结论:血清NT-proBNP的定量检测可为快速性心律失常的诊断及预后评估提供直接病理生理学依据。 Objective:To investigate the changes of N terminal pro brain natriuretic peptide(NT-proBNP)in serum before and after cardioversion in children with tachyarrhythmia.We evaluated its clinical diagnosis,prognosis evaluation for arrhythmias.Methods:60 patients with tachyarrhythmia in children were selected.We determined the level of NT-proBNP in serum,left ventricular ejection fraction(EF) and left ventricular end diastolic diameter(LVDD) before and after the cardioversion of tachyarrhythmia.60 healthy children were selected as the control group,they were also determined the serum NT-proBNP level and EF,LVDD.Results:The level of NT-proBNP before the tachyarrhythmia cardioversion were significantly higher than that after the tachyarrhythmia cardioversion and the control group,there were statistically significant.There were no statistical significance between the NT-proBNP level of after tachyarrhythmia cardioversion 1 weeks and that of the healthy control group.There were no statistical significance among the EF,LVDD of before the tachyarrhythmia cardioversion and after cardioversion for a week and the healthy control group.Conclusion:It can provide direct pathophysiological basis for diagnosis and prognostic evaluation of tachyarrhythmia by the quantitative detection of serum NT-proBNP.
作者 孙晓敏
出处 《中国社区医师(医学专业)》 2014年第10期101-101,103,共2页
关键词 快速性心律失常 脑利钠肽 Rapid arrhythmia Brain natriuretic peptide
  • 相关文献

参考文献2

  • 1雷甿甿,谢毅,吴立荣,李屏,马启玲,张长海.利钠肽类激素在心律失常后的变化[J].临床心电学杂志,2008,17(3):197-198. 被引量:1
  • 2Quyen Dao,Padma Krishnaswamy,Radmila Kazanegra,Alex Harrison,Rambod Amirnovin,Leslie Lenert,Paul Clopton,Joel Alberto,Patricia Hlavin,Alan S Maisel.Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting[J].Journal of the American College of Cardiology.2001(2)

二级参考文献4

  • 1Vijaya K.Munagala, John C.Burnett,Jr, Margaret M.Redfield. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol. 2004;29:707-769.
  • 2Molhoek SG. Atrial and brain natriuretic peptides as markers of response to resynchonization therapy. Heart.2004;90(1):97.
  • 3Moe GW, Grima EA, Wong NL, Howard RJ, et al. Plasma and cardiac tissue atrial and brain natriuretic peptides in experiments heart fail.ure. J Am Coll Cardiol.1996.27(3):720-727.
  • 4Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects.The Euro J of Heart Failure.2004; 261-268.

共引文献1

同被引文献10

引证文献1

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部